Is BRAF mutation screening useful for preoperative risk stratification in papillary thyroid cancer?

Author： Soares Paula   Sobrinho-Simõões Manuel  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.5, Iss.8, 2009-10, pp. : 1225-1229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk Management

By Xing Mingzhao  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 801-803

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma

By He Guoping   Zhao Baojian   Zhang Xu   Gong Rixiang  

Oncology Letters, Vol. 7, Iss. 2, 2014-02 ,pp. : 439-443

Spandidos Publications

Access to resources Recommend Favorite

Multicentric occurrence of multiple papillary thyroid carcinomas –HUMARA and BRAF mutation analysis

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1272-1280

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRAF mutation is not predictive of long‐term outcome in papillary thyroid carcinoma

By  

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 791-799

John Wiley & Sons Inc

Access to resources Recommend Favorite

The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma

By Lin Kuai-Lu  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3294-3300

Springer Publishing Company

Access to resources Recommend Favorite